Jounce Therapeutics, Inc.

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

47,800

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q1 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	88	0.0%	47,800	3/31/2023
2022 Q4	2/14/2023	422	0.0%	380,500	12/31/2022
2022 Q3	11/14/2022	664	0.0%	283,800	9/30/2022
2022 Q2	8/15/2022	971	0.0%	320,500	6/30/2022
2022 Q1	5/16/2022	2,217	0.0%	326,500	3/31/2022
2021 Q4	2/14/2022	4,388	0.0%	525,500	12/31/2021
2021 Q3	11/15/2021	2,797	0.0%	376,500	9/30/2021
2021 Q2	8/16/2021	1,480	0.0%	217,600	6/30/2021
2021 Q1	5/17/2021	850	0.0%	82,800	3/31/2021
2020 Q2	9/15/2020	175	0.0%	25,300	6/30/2020
2020 Q1	5/15/2020	235	0.0%	49,400	3/31/2020
2019 Q4	2/14/2020	1,031	0.0%	118,100	12/31/2019